0001493152-24-015879.txt : 20240425
0001493152-24-015879.hdr.sgml : 20240425
20240425113735
ACCESSION NUMBER: 0001493152-24-015879
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240425
DATE AS OF CHANGE: 20240425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CZIRR JAMES C
CENTRAL INDEX KEY: 0001260641
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 24874115
MAIL ADDRESS:
STREET 1: 4908 SOUTH ASHTON COURT
CITY: SPOKANE
STATE: WA
ZIP: 99223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
5
1
ownership.xml
X0508
5
2023-12-31
0
0
0
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001260641
CZIRR JAMES C
4908 S. ASHTON CT.
SPOKANE,
WA
99223
0
0
1
0
0
Common Stock
2023-03-31
5
J
0
1000
6.00
A
761616
D
Common Stock
2023-09-30
5
J
0
1000
6.00
A
762616
D
Common stock received in satisfaction of $6,000 of dividends due on Series A Convertible Preferred Stock owned by James C. Czirr pursuant to issuer's option to pay dividends in cash or common stock, at its sole discretion. The dividends were payable on 3/31/2020 and 9/30/2020. The price is the amount of the dividend divided by the number shares issued in satisfaction of the dividend.
Exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16a-9.
/s/ James C. Czirr
2024-04-25